Quest Diagnostics to Develop MCaST Blood Test
Quest Diagnostics is partnering with MD Anderson Cancer Center to develop a lab-based blood test for cancer that uses protein biomarkers.
Read MorePosted by Chris Wolski | Jun 11, 2025 | Cancer |
Quest Diagnostics is partnering with MD Anderson Cancer Center to develop a lab-based blood test for cancer that uses protein biomarkers.
Read MorePosted by Chris Wolski | Feb 7, 2025 | Company News |
Summary:BD (Becton, Dickinson and Company) announced its plan to separate its Biosciences and...
Read MorePosted by Andy Lundin | Dec 17, 2024 | Diagnostic Technologies |
Researchers have developed microchips that can identify multiple diseases from a single cough or air sample.
Read MorePosted by Andy Lundin | Dec 11, 2024 | Clinical Chemistry |
A new study reveals that personalized setpoints in complete blood count tests could enable earlier of diseases.
Read MorePosted by Andy Lundin | Nov 13, 2024 | Microscopy |
A new AI-driven tool enables neurosurgeons to detect residual brain tumor tissue in seconds, reducing the likelihood of cancer recurrence.
Read More